Premium
ChrysCapital, which hit the milestone of raising the largest-ever sector-agnostic private equity fund focused on India last year and has built a reputation for several big-ticket exits in the country and a strong healthcare investment franchise, is trimming its stake in Mankind Pharma via the company’s initial public offering. The ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
